New Pfizer to buy Array BioPharma in deal worth $11.4 billion
NEW YORK (AP) - Pfizer is delving deeper into cancer research with a roughly $11.4 billion deal for Array BioPharma, a drug developer that has seen its shares soar since announcing…
NEW YORK (AP) - Pfizer is delving deeper into cancer research with a roughly $11.4 billion deal for Array BioPharma, a drug developer that has seen its shares soar since announcing…